# DuoTrav® Eye Drops As Replacement Therapy Program

> **NCT00828906** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 128 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** DuoTrav

## Key facts

- **NCT ID:** NCT00828906
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-11
- **Final completion:** —
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2012-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828906, "DuoTrav® Eye Drops As Replacement Therapy Program". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00828906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*